Link Between Estimated Glucose Disposal Rate and Overall as well as Breast Cancer-Specific Mortality in Survivors: A Population-Based Analysis in the United States - Scorecard - MDSpire
Advertisement
Link Between Estimated Glucose Disposal Rate and Overall as well as Breast Cancer-Specific Mortality in Survivors: A Population-Based Analysis in the United States
Clinical Scorecard: Link Between Estimated Glucose Disposal Rate and Overall as well as Breast Cancer-Specific Mortality in Survivors: A Population-Based Analysis in the United States
At a Glance
Category
Detail
Condition
Breast Cancer
Key Mechanisms
Insulin resistance (IR) and its association with glucose disposal rate (eGDR) impacting breast cancer prognosis.
Target Population
Women with a history of breast cancer.
Care Setting
Population-based analysis using NHANES database.
Key Highlights
Breast cancer is a leading cause of cancer-related deaths in women.
Insulin resistance is linked to poorer prognosis in breast cancer patients.
Estimated glucose disposal rate (eGDR) serves as a non-invasive marker for insulin sensitivity.
Lower eGDR is associated with higher all-cause mortality (ACM) in breast cancer survivors.
The study utilizes data from 2007-2016 NHANES to analyze the relationship between eGDR and breast cancer outcomes.
Guideline-Based Recommendations
Diagnosis
Utilize self-reported questionnaires for breast cancer diagnosis in population studies.
Management
Consider metabolic interventions targeting insulin resistance in breast cancer survivors.
Monitoring & Follow-up
Monitor eGDR levels as a potential indicator of prognosis in breast cancer patients.
Risks
Assess risks associated with lower eGDR, including increased ACM and breast cancer-specific mortality.
Patient & Prescribing Data
Breast cancer survivors identified through NHANES.
Standard endocrine therapy is common among HR+/Her2- breast cancer patients, which may induce metabolic sequelae.
Clinical Best Practices
Implement regular assessment of insulin resistance in breast cancer survivors.
Utilize eGDR as a tool for identifying high-risk patients for targeted interventions.
